참고문헌
- ASHP (American Society of Hospital Pharmacists) : ASHP technical assistance bulletin on handling cytotoxic and hazardous drugs. Am. J. Hosp. Pharm. 47, 1033 (1990).
- NIOSH (National Institute for Occupational Safety and Health) : NIOSH alert: Preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings. www.cdc.gov/niosh/docs/ 2004-165/.
- Sessink, P. J. M. and Bos, R. P. : Drugs hazardous to healthcare workers: evaluation of methods for monitoring occupational exposure to cytostatic drugs. Drug. Saf. 20, 347 (1999). https://doi.org/10.2165/00002018-199920040-00004
- ASHP (American Society of Hospital Pharmacists) : ASHP guidelines on handling hazardous drug. Am. J. Health-Syst. Pharm. 63, 1172 (2006). https://doi.org/10.2146/ajhp050529
- IARC (International Agency for Research on Cancer) : IARC monographs: chemicals and industrial processes associated with cancer in humans. Lyons, France (1979).
- Falck, K., Grohn, P., Sorsa, M., Vainio, H., Heinonen, E. and Holsti, L. R. : Mutagenicity in urine of nurses handling cytostatic drugs. Lancet. 1, 1250 (1979).
- Sessink, P. J. M., Anzion, R. B. M., Van der Broek, P. H. H. and Bos, R. P. : Detection of contamination with antineoplastic agents in a hospital pharmacy department. Pharm. Week. Sci. 14, 16 (1992). https://doi.org/10.1007/BF01989220
- Connor, T. H., Anderson, R. W., Sessink, P. J., Broadfield, L. and Power, L. A. : Surface contamination with antineoplastic agents in six cancer treatment centers in Canada and the United States. Am. J. Health Syst. Pharm. 56, 1427 (1999).
- Schmaus, G., Schierl, R. and Funck, S. : Monitoring surface contamination by antineoplastic drugs using gas chromatography mass spectrometry and voltammetry. Am. J. Health Syst. Pharm. 59, 956 (2002).
- Soave, C., Giuliari, C., Bartolucci, G. B., Carrieri, M., Festa, D., Sannolo, N., Miraglia, N., Acampora, A. and Viotti, P. L. : Cyclophosphamide environmental contamination in drug reconstitution units in twenty one Italian hospitals. EJHP 6, 15 (2003).
- Wick, C., Slawson, M. H., Jorgenson, J. A. and Tyler, L. S. : Using a closed-system protective device to reduce personnel exposure to antineoplastic agents. Am. J. Health Syst. Pharm. 60, 2314 (2003).
- Mason, H. J., Blair, S., Sams, C., Jones, K., Garfitt, S. J., Cuschieri, M. J. and Baxter, P. J. : Exposure to Antineoplastic drugs in two UK hospital pharmacy units. Ann. Occup. Hyg. 49, 603 (2005). https://doi.org/10.1093/annhyg/mei023
- Acampora, A., Castiglia, L., Miraglia, N., Pieri, M., Soave, C., Liotti, F. and Sannolo, N. : A case study: surface contamination of cyclophosphamide due to working practices and cleaning procedures in two Italian hospitals. Ann. Occup. Hyg. 49, 611 (2005). https://doi.org/10.1093/annhyg/mei029
- Hedmer, M., Georgiadi, A., Bremberg, E. R., Jonsson, B. A. and Eksborg, S. : Surface contamination of cyclophosphamide packaging and surface contamination with antineoplastic drugs in a hospital pharmacy in Sweden. Ann. Occup. Hyg. 49, 629 (2005). https://doi.org/10.1093/annhyg/mei042
- Fransman, W., Peelen, S., Hilhorst, S., Roeleveld, N., Heederik, D. and Kromhout, H. : A pooled analysis to study trends in exposure to antineoplastic drugs among nurses. Ann. Occup. Hyg. 51, 231 (2007).
- Hedmer, M., Tinnerberg, H., Axmon, A. and Jonsson, B. A. : Environmental and biological monitoring of antineoplastic drugs in four workplaces in a Swedish hospital. Int. Arch. Occup. Environ. Health 81, 899 (2008). https://doi.org/10.1007/s00420-007-0284-y
- Castiglia, L., Miraglia, N., Pieri, M., Simonelli, A., Basilicata, P., Genovese, G., Guadagni, R., Acampora, A., Sannolo, N. and Scafarto, M. V. : Evaluation of occupational exposure to antiblastic drugs in an Italian hospital oncological department. J. Occup. Health 50, 48 (2008). https://doi.org/10.1539/joh.50.48
- Martins, I., Apostoli, P. and Della Rosa, H. V. : Cyclophosphamide levels in sites of preparation and administration of antineoplastic drugs. Lat. Am. J. Pharm. 27, 217 (2008).
- Yoshida, J., Tei, G., Mochizuki, C., Masu, Y., Koda, S. and Kumagai, S. : Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment. Ann. Occup. Hyg. 53, 153 (2009). https://doi.org/10.1093/annhyg/men081
- Sessink, P. J. M., Boer, K. A., Scheefhals, A. P. H., Anzion, R. B. M. and Bos, R. P. : Occupational exposure to antineoplastic agents at several departments in a hospital: environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers. Int. Arch. Occup. Environ. Health 64, 105 (1992). https://doi.org/10.1007/BF00381477
- McDevitt, J., Lees, P. and McDiarmid, M. : Exposure of hospital pharmacists and nurses to antineoplastic drugs. J. Occup. Med. 35, 57 (1993).
- Sessink, P. J. M., Van der Kerkhof, M. C. A., Anzion, R. B. M., Noordhoek, J. and Bos, R. P. : Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: is skin absorption an important exposure route? Arch. Environ. Health 49, 165 (1994). https://doi.org/10.1080/00039896.1994.9940377
- Sessink, P. J. M., Wittenhorst, B. C., Anzion, R. B. and Bos, R. P. : Exposure of pharmacy technicians to antineoplastic agents - reevaluation after additional protective measures. Arch. Environ. Health 52, 240 (1997). https://doi.org/10.1080/00039899709602893
- Larson, R. R., Khazaeli, M. B. and Dillon, H. K. : Monitoring method for surface contamination caused by selected antineoplastic agents. Am. J. Health Syst. Pharm. 59, 270 (2002).
- Pethran, A., Schierl, R., Hauff, K., Grimm, C. H., Boos, K. S. and Nowak, D. : Uptake of antineoplastic agents in pharmacy and hospital personnel. Part I: monitoring of urinary concentrations. Int. Arch. Occup. Environ. Health 76, 5 (2003).
- 김소정 : 항암제에 폭로된 간호사들의 염색체 이상과 자매염색체 교환빈도. 석사학위논문, 서울대학교 (1995).
- 김봉임 : 항암제 취급 간호사의 소변중 돌연변이 유발능과 자각증상 및 스트레스. 박사학위논문, 경북대학교 (1996).
- 신혜숙, 이세훈 : 간호사에서 항암제 취급양상과 건강증상. 대한산업의학지 8, 228 (1996).
- 김봉임 : 항암제 취급간호사의 항암제 체내흡수에 관한 조사. 간호학회지 27, 520 (1997).
- 최봉규 : 종합병원 근무 간호사와 약사의 항암제 노출에 관한 연구. 석사학위논문, 서울대학교 (1999).
- Turci, R., Sottani, C., Spagnoli, G. and Minoia, C. : Biological and environmental monitoring of hospital personnel exposed to antineoplastic agents: a review of analytical methods. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 789, 169 (2003). https://doi.org/10.1016/S1570-0232(03)00100-4
- IARC (International Agency for Research on Cancer) : IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Lyons, France (2004).
- Product Information: Cytoxan(R), cyclophosphamide. Bristol-Myers Squibb, Princeton, NJ, USA.
- Hedmer, M., Hoglund, P., Cavallin-Stahl, E., Albin, M. and Jonsson, B. A. : Validation of urinary excretion of cyclophosphamide as a biomarker of exposure by studying its renal clearance at high and low plasma concentrations in cancer patients. Int. Arch. Occup. Environ. Health 81, 285 (2008).
- Connor, T. H., Shults, M. and Fraser, M. P. : Determination of the vaporization of solutions of mutagenic antineoplastic agents at 23 and 37 degrees using a desiccator technique. Mutat. Res. 470, 85 (2000). https://doi.org/10.1016/S1383-5718(00)00105-4
- Hedmer, M., Jonsson, B. A. and Nygren, O. : Development and validation of methods for environmental monitoring of cyclophosphamide in workplaces. J. Environ. Monit. 6, 979 (2004). https://doi.org/10.1039/b409277e
- Harrison, B. R. : Safety handling cytotoxic drugs. The chemotherapy source book. 2nd ed. Williams & Wilkins, 905-945 (1996).
- Sottani, C., Turci, R., Perbellini, L. and Minoia, C. : Liquidliquid extraction procedure for trace determination of cyclophosphamide in human urine by high-performance liquid chromatography tandem mass spectrometry. Rapid Commun. Mass. Spectrom. 12, 1063 (1998). https://doi.org/10.1002/(SICI)1097-0231(19980831)12:16<1063::AID-RCM287>3.0.CO;2-K
- Turci, R. and Minoia, C. : Residual hazard assessment related to handling of antineoplastic drugs: safety system evolution and quality assurance of analytical measurement. Ann. N Y Acad. Sci. 1076, 649 (2006). https://doi.org/10.1196/annals.1371.047
- Mason, H. J., Morton, J., Garfitt, S. J., Iqbal, S. and Jones, K. : Cytotoxic drug contamination on the outside of vials delivered to a hospital pharmacy. Ann. Occup. Hyg. 47, 681 (2003). https://doi.org/10.1093/annhyg/meg078
- Connor, T. H., Sessink, P. J., Harrison, B. R., Pretty, J. R., Peters, B. G., Alfaro, R. M., Bilos, A., Beckmann, G., Bing, M. R., Anderson, L. M. and Dechristoforo, R. : Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: results of three studies. Am. J. Health Syst. Pharm. 62, 475 (2005).
- Touzin, K., Bussieres, J. F., Langlois, E., Lefebvre, M. and Gallant, C. : Cyclophosphamide contamination observed on the external surfaces of drug vials and the efficacy of cleaning on vial contamination. Ann. Occup. Hyg. 52, 765 (2008). https://doi.org/10.1093/annhyg/men050
- Connor, T. H. and McDiarmid, M. A. : Preventing occupational exposures to antineoplastic drugs in health care settings. CA Cancer. J. Clin. 56, 354 (2006). https://doi.org/10.3322/canjclin.56.6.354
- Hansel, S., Castegnaro, M., Sportouch, M. H. et al. : Chemical degradation of wastes of antineoplastic agents: cyclophosphamide, ifosfamide, and melphalan. Int. Arch. Occup. Environ. Health 69, 109 (1997).
- Dranitsaris, G., Johnston, M., Poirier, S., Schueller, T., Milliken, D., Green, E. and Zanke, B. : Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature. J. Oncol. Pharm. Pract. 11, 69 (2005). https://doi.org/10.1191/1078155205jp155oa
- Sessink, P. J., Kroese, E. D., van Kranen, H. J. and Bos, R. P. : Cancer risk assessment for health care workers occupationally exposed to cyclophosphamide. Int. Arch. Occup. Environ. Health 67, 317 (1995). https://doi.org/10.1007/BF00385647